DK0574355T3 - Phosphinyloxypropanaminium-indre saltderivater - Google Patents

Phosphinyloxypropanaminium-indre saltderivater

Info

Publication number
DK0574355T3
DK0574355T3 DK93810406.4T DK93810406T DK0574355T3 DK 0574355 T3 DK0574355 T3 DK 0574355T3 DK 93810406 T DK93810406 T DK 93810406T DK 0574355 T3 DK0574355 T3 DK 0574355T3
Authority
DK
Denmark
Prior art keywords
phosphinyloxypropanaminium
inner salt
salt derivatives
thiolysis
thiolation
Prior art date
Application number
DK93810406.4T
Other languages
Danish (da)
English (en)
Inventor
Robert Charles Anderson
Gregory R Bebernitz
James D Fraser
Jeffrey W Hughes
Prasad K Kapa
Mahavir Prashad
Howard C Smith
Edwin B Willhauer
Original Assignee
Sandoz Ag
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag, Ciba Geigy Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of DK0574355T3 publication Critical patent/DK0574355T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • C07F9/1651Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/113Esters of phosphoric acids with unsaturated acyclic alcohols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DK93810406.4T 1992-06-11 1993-06-07 Phosphinyloxypropanaminium-indre saltderivater DK0574355T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89721092A 1992-06-11 1992-06-11

Publications (1)

Publication Number Publication Date
DK0574355T3 true DK0574355T3 (da) 1998-01-26

Family

ID=25407534

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93810406.4T DK0574355T3 (da) 1992-06-11 1993-06-07 Phosphinyloxypropanaminium-indre saltderivater

Country Status (21)

Country Link
EP (1) EP0574355B1 (ja)
JP (1) JPH0673077A (ja)
KR (1) KR940005647A (ja)
CN (1) CN1039326C (ja)
AT (1) ATE156828T1 (ja)
AU (1) AU667537B2 (ja)
CA (1) CA2098133A1 (ja)
CZ (1) CZ108393A3 (ja)
DE (1) DE69313029T2 (ja)
DK (1) DK0574355T3 (ja)
ES (1) ES2105194T3 (ja)
FI (1) FI932662A (ja)
GR (1) GR3024684T3 (ja)
HU (2) HUT65327A (ja)
IL (1) IL105965A (ja)
MY (1) MY109005A (ja)
NO (1) NO932096L (ja)
NZ (1) NZ247840A (ja)
SG (1) SG42983A1 (ja)
SK (1) SK58893A3 (ja)
ZA (1) ZA934157B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
DE602004029319D1 (de) 2003-02-18 2010-11-11 Univ Tokai Verbindung mit phoshorylcholingruppe, dessen polymer und verfahren zu dessen herstellung
KR20090034969A (ko) 2006-08-02 2009-04-08 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 씨피티-억제제로서 4-트라이메틸암모늄-3-아미노부티레이트및 4-트라이메틸포스포늄-3-아미노부티레이트의 유도체
KR20220054351A (ko) 2019-08-30 2022-05-02 인스티튜트 오브 주올로지, 차이니즈 아카데미 오브 사이언스 대사 질환의 예방을 위해 사용된 조성물 및 조성물의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348859A1 (en) * 1988-07-01 1990-01-03 MAGIS FARMACEUTICI S.p.A. 1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them
IT1231751B (it) * 1989-04-12 1991-12-21 Sigma Tau Ind Farmaceuti Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
IT1230141B (it) * 1989-05-03 1991-10-14 Fidia Spa Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
IT1230142B (it) * 1989-05-03 1991-10-14 Fidia Spa Derivati della carnitina, processo per la loro preparazione e impiego in terapia umana

Also Published As

Publication number Publication date
AU667537B2 (en) 1996-03-28
ATE156828T1 (de) 1997-08-15
AU4011593A (en) 1993-12-16
CA2098133A1 (en) 1993-12-12
SK58893A3 (en) 1994-06-08
NO932096D0 (no) 1993-06-09
HU211489A9 (en) 1995-11-28
GR3024684T3 (en) 1997-12-31
EP0574355B1 (en) 1997-08-13
ES2105194T3 (es) 1997-10-16
EP0574355A1 (en) 1993-12-15
ZA934157B (en) 1994-09-05
NZ247840A (en) 1995-04-27
CN1039326C (zh) 1998-07-29
HU9301587D0 (en) 1993-09-28
DE69313029D1 (de) 1997-09-18
JPH0673077A (ja) 1994-03-15
MY109005A (en) 1996-11-30
FI932662A0 (fi) 1993-06-10
IL105965A0 (en) 1993-10-20
CZ108393A3 (en) 1995-02-15
NO932096L (no) 1993-12-13
KR940005647A (ko) 1994-03-22
SG42983A1 (en) 1997-10-17
IL105965A (en) 1997-03-18
HUT65327A (en) 1994-05-02
DE69313029T2 (de) 1998-01-29
FI932662A (fi) 1993-12-12
CN1086217A (zh) 1994-05-04

Similar Documents

Publication Publication Date Title
AU1282495A (en) Anthranilic acid derivative
ES552722A0 (es) Un procedimiento para preparar un complejo liposoluble de platino divalente.
ZA901834B (en) Trifluoromethylphenylazolylmethyloxiranes,the preparation thereof and the use thereof as crop protection agents
AU7659687A (en) Sulphonamide containing phenoxyacetic acid derivatives and their preparation
AU8491691A (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
DK0574355T3 (da) Phosphinyloxypropanaminium-indre saltderivater
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
ATE236162T1 (de) Pyrroloazepinderivate
AU1406888A (en) Biologically active compounds
DE69511449T2 (de) Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung
ATE158585T1 (de) Substituierte bizyklische oxazol- und thiazol- äther